Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2008; 133(49): 2567-2571
DOI: 10.1055/s-0028-1105855
DOI: 10.1055/s-0028-1105855
Aktuelle Diagnostik & Therapie | Review article
Endokrinologie, Urologie
© Georg Thieme Verlag KG Stuttgart · New York
Gynäkomastie: Diagnostik und Therapie
Gynecomastia: diagnostic and therapyFurther Information
Publication History
eingereicht: 17.2.2008
akzeptiert: 13.11.2008
Publication Date:
27 November 2008 (online)
Schlüsselwörter
Gynäkomastie - Pubertät - Anabolika - viriles Mammakarzinom - antiandrogene Therapie Prostatakarzinom - Tamoxifen - Klinefelter-Syndrom
Key words
gynecomastia - puberty - anabolic steroids - male breast cancer - antiandrogene treatment prostate cancer - tamoxifen - Klinefelter’s syndrome
Literatur
- 1 Autorino R, Perdona S. et al . Gynecomastia in patients with prostate cancer: update on treatment options. rostate Cancer Prostatic Dis. 2006; 9 109-114
- 2 Boccardo F, Rubagotti A. et al . Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol. 2005; 23 808-815
- 3 Braunstein G D. Clinical practice. Gynecomastia. N Engl J Med. 2007; 357 1229-1237
- 4 Carvajal A, Macias D. et al . Gynaecomastia associated with proton pump inhibitors: a case series from the Spanish Pharmacovigilance System. Drug Saf. 2007; 30 527-531
- 5 Chalazonitis A N, Theodossiades G D. et al . Bilateral gynecomastia with microcalcifications in an HIV infected hemophilia A patient after HAART. Jbr-Btr. 2006; 89 328
- 6 Cuculi F, Suter A. et al . Spironolactone-induced gynecomastia. CMAJ. 2007; 176 620
- 7 DDG, L.v. d. S.A.d. D.D.G. AWMF-Leitlinien 2004; Register Nr. 013/039.
- 8 de la Torre A, Ramada Benlloch F, Sánchez Ballester F. et al . Management of male sterility in patients taking anabolic steroids. Arch Esp Urol. 2005; 58 241-244
- 9 Di Lorenzo G, Perdona S. et al . Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy. J Urol. 2005; 174 2197-2203
- 10 Ewertz M, Holmberg L. et al . Risk factors for male breast cancer – a case-control study from Scandinavia. Acta Oncol. 2001; 40 467-471
- 11 Fradet Y, Egerdie B. et al . Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study. Eur Urol. 2007; 52 106-114
- 12 Giordano S H. A review of the diagnosis and management of male breast cancer. Oncologist. 2005; 10 471-479
- 13 Henley D V, Lipson N. et al . Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007; 356 479-485
- 14 Hochberg Z. Practical Algorithms in Pediatric Endocrinology. Freiburg; Karger 2007
- 15 Karagiannis A, Tziomalos K. et al . Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism. Nephrol Dial Transplant. 2007; 22 293
- 16 Khan H N, Blamey R W. Endocrine treatment of physiological gynaecomastia. BMJ. 2003; 327 301-302
- 17 Khan H N, Rampaul R. et al . Management of physiological gynaecomastia with tamoxifen. Breast. 2004; 13 61-65
- 18 Kliesch S, Behre H M. et al . Rationale Therapie der Hitzewallungen unter Hormonentzugsbehandlung bei Patienten mit fortgeschrittenem Prostatakarzinom. Dtsch Med Wochenschr. 1997; 122 940-945
- 19 Lazala C, Saenger P. Pubertal gynecomastia. J Pediatr Endocrinol Metab. 2002; 15 553-560
- 20 Narula H S, Carlson H E. Gynecomastia. Endocrinol Metab Clin North Am. 2007; 36 497-519
- 21 Nuttall M C, Harris J P. et al . The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain. BJU Int. 2007; 99 243-244
- 22 Perdona S, Autorino R. et al . Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol. 2005; 6 295-300
- 23 Prisant L M, Chin E. Gynecomastia and hypertension. J Clin Hypertens (Greenwich). 2005; 7 245-248
- 24 Rose L I, Underwood R H. et al . Pathophysiology of spironolactone-induced gynecomastia. Ann Intern Med. 1977; 87 398-403
- 25 Smith R A, Saslow D. et al . American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003; 53 141-169
- 26 Tashkandi M, Al-Qattan M M. et al . The surgical management of high-grade gynecomastia. Ann Plast Surg. 2004; 53 17-20
- 27 Than RS, Vasudevan D. Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse. Fertil Steril. 2003; 79
- 28 Thonnessen D, Wenz F. Radiotherapeutic prophylaxis of gynecomastia. J Clin Oncol. 2005; 23 5845
- 29 UpToDate Prevention and treatment of gynecomastia, UpToDate 2007 95 Sawyer Road Waltham, MA 02453 United States.
- 30 Yavuz M, Kesiktas E. et al . Lighted retractor-assisted transaxillary approach in gynecomastia correction. Ann Plast Surg. 2006; 57 370-373
- 31 Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab. 2004; 89 6208-6217
Dipl. Med. Jens W. Jacobeit
Internist – Endokrinologe – Androloge, ENDOKRINOLOGIKUM Hamburg
Lornsenstr. 4 – 6
22767
Hamburg
Email: jens.jacobeit@endokrinologikum.com